What is Segal Trials?
Founded in 1998, Segal Trials operates a network of seven research sites across South Florida and South Carolina, specializing in Phase I-IV clinical trials. The company places a strong emphasis on psychiatry, neurology, insomnia, and women's health. With a team of over 120 professionals, Segal Trials has been instrumental in the development of 26 FDA-approved medications. Beyond conducting trials, the organization offers comprehensive services including data management, bioanalytical lab analysis, and project management, positioning itself as an innovator in advancing medicine and serving its community by raising awareness about clinical trial participation as a healthcare option.
How much funding has Segal Trials raised?
Segal Trials has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Segal Trials?
The substantial capital infusion, indicated by the $350K in total funding and the recent $350K strategic investment, signals Segal Trials' readiness for accelerated expansion and enhanced operational capabilities. As a late-stage company, this financing is likely to be deployed towards scaling its research infrastructure, expanding its therapeutic area focus, and potentially exploring new geographic markets. The company's commitment to quality and patient-centricity, coupled with its proven track record in bringing life-improving medications to market, positions it for continued success and leadership in the clinical research sector.
See full Segal Trials company page
